iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 3,070.00
-25.00 (-0.81%)
May 20, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 97.05 billion as of May 20, 2026. Its market cap has decreased by -26.38% in one year.
Market Cap
97.05B
Enterprise Value
58.63B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,070.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 97.05B, an increase of 1.84%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 97.05B | -5.54% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 148.20B |
| GeneOne Life Science | 148.16B |
| MedPacto | 141.38B |
| Vaxcell-Bio Therapeutics | 137.68B |
| Amicogen | 127.03B |
| ENCell | 126.08B |
| Prestige BioPharma | 88.10B |
| CG Invites | 86.12B |